Alcanza Clinical Research Announces Strategic Acquisition of CNS Healthcare
Submit Your Information
Create a Profile
Get In Touch Mobile
John Mark Joyce, MD
Dr. John Mark Joyce has been a Principal Investigator at the Jacksonville clinic since 2003. He has participated in over 400 Pediatric, Adolescent, Adult, and Geriatric Ph II – IV clinical trials including Psychiatry, Neurology, Women’s Health, Pain, Addictions, Vaccine, Dermatology, GI, Sleep, Diabetes and Obesity.
Dr. Joyce also holds a Schedule I license and has been on the forefront of psychedelic research and education in the Jacksonville area. Throughout his research career his contributions have been instrumental in bringing 108 new drugs to market and is frequently sought out by Sponsors for his high enrollment and clean, outstanding data quality. In his 22 years at CNS Healthcare, Dr. Joyce has successfully completed numerous FDA audits for high enrollment with no 483’s.
Although Board Certified in Psychiatry, Dr. Joyce’s passion is in Obesity and Metabolism. He has been an Investigator in numerous Diabetes, Obesity, Metabolic and Cardiovascular trials and likes to stay on top of the latest research findings.
Articles
Alcanza Clinical Research Announces Strategic Acquisition of CNS Healthcare
Jim Leary Joins Alcanza as Chief Information Officer
Alcanza Clinical Research Announces Launch of Enspire Clinical Research in Illinois
Ready to be part of healthcare history? Find the right clinical trial for you.
